Best Drug Discovery Software - Page 9

Nostrum Suite

Nova In Silico

NoviSight 3D

NoviSight 3D cell analysis software provides statistical data for spheroids and other 3D objects in microplate-based experiments.

Numerion Labs

Nygen

Nygen empowers leading experimental biologists to generate deep, actionable insights from their single-cell omics data. Our product suite is designed to help researchers unlock the full potential of single-cell data, driving innovation in clinical trials, diagnostics, and therapeutic decision-making with robust, scalable solutions. Nygen Analytics Our flagship platform for single-cell multi-omics analysis combines no-code pipelines, reproducibility, traceability, and a highly scalable infrastructure. It also supports seamless data hosting and result publishing to streamline your research workflow. Nygen Database An open-access, curated single-cell database that includes datasets spanning hundreds of cell types. Nygen Database enables the exploration and integration of millions of cells, simplifying full-cycle data management and fostering collaboration. Nygen Insights Featuring LLM-augmented knowledge distillation, Nygen Insights automates cell annotations and delivers disease-specific insights. These powerful capabilities accelerate drug discovery and therapeutic advancements by providing researchers with actionable results tailored to their data. Nygen is your complete solution for turning single-cell data into groundbreaking discoveries.

Onepot AI

Onepot AI offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process.

OpenEye

OpenEye Scientific, now part of Cadence, specializes in computational molecular design to accelerate scientific innovation. Its flagship Orion platform offers cloud-based solutions for virtual screening, molecular dynamics, and quantum chemistry, enabling the exploration of billions of molecular compounds at unprecedented speed and scale. With advanced tools for drug discovery, antibody engineering, and pharmaceutical formulations, OpenEye empowers researchers in biotech, pharmaceuticals, and academia to achieve breakthrough results through physics-based design and cutting-edge algorithms.

Ordaos Bio

Output Biosciences

Output Biosciences is at the forefront of integrating artificial intelligence with biotechnology to revolutionize the understanding and treatment of complex biological systems. By developing Biologically-Aware Generative AI, the company constructs Large Biological Models capable of processing intricate, high-dimensional biological data. This innovative approach aims to transform the diagnosis, treatment, and prevention of diseases by generating breakthrough medicines. Key Features and Functionality: - Biologically-Aware Generative AI: Tailored AI systems designed to comprehend and model complex biological processes. - Large Biological Models: Advanced models capable of analyzing extensive and intricate biological datasets. - High-Dimensional Data Processing: Ability to handle nonlinear, fragmented, and high-dimensional biological information. - Accelerated Drug Discovery: Facilitation of rapid development and manufacturing of novel therapeutics. - Comprehensive Disease Management: Enhancement of disease diagnosis, treatment, and prevention strategies. Primary Value and User Solutions: Output Biosciences addresses the challenges inherent in understanding complex biological systems by leveraging AI to interpret and model biological data effectively. This capability enables the rapid discovery and development of new medicines, significantly reducing the time and resources traditionally required in drug development. By transforming how diseases are diagnosed, treated, and prevented, Output Biosciences offers substantial value to pharmaceutical companies, biotech startups, and research institutions seeking innovative solutions in healthcare.

Palladium DEL Follow-Up Suite

Panakeia

Pando Bioscience

Pando Bioscience is an AI-driven synthetic biology company revolutionizing enzyme engineering for pharmaceutical manufacturing and diagnostics. By integrating artificial intelligence with an ultra-high-throughput screening platform, Pando accelerates enzyme development, screening 1,000 times more enzymes 75% faster and at 80% lower cost than traditional methods. This approach enables the efficient optimization of enzymes across multiple properties, delivering high-performing, industrial-grade enzymes that create and capture new market value. Key Features and Functionality: - AI-Driven Enzyme Engineering: Utilizes generative AI models to design and optimize enzyme sequences, enhancing activity, stability, and manufacturability. - Ultra-High-Throughput Screening: Employs a proprietary platform capable of screening a vast number of enzyme variants rapidly and cost-effectively. - Custom Enzyme Solutions: Offers tailored enzyme development services to meet specific client needs in pharmaceutical manufacturing and diagnostics. - Proprietary Engineered Enzymes: Provides high-performing enzymes designed for molecular biology applications, ensuring superior performance and reliability. Primary Value and Solutions: Pando Bioscience addresses the challenges of developing industrial-grade enzymes by significantly reducing the time and cost associated with enzyme optimization. Their AI-guided iterative improvement process ensures enzymes possess a balanced set of properties, such as enhanced activity, stability, and manufacturability. This leads to increased efficiency and profitability for clients in the pharmaceutical and diagnostics industries, enabling them to bring products to market faster and more cost-effectively.

Partex

PathExplore

Pepticom